Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 130

1.

Prognostic Value and Therapeutic Implication of Laparoscopic Extraperitoneal Paraaortic Staging in Locally Advanced Cervical Cancer: A Spanish Multicenter Study.

Díaz-Feijoo B, Torné A, Tejerizo Á, Benito V, Hernández A, Ruiz R, Domingo S, Luna-Guibourg R, Llueca A, Coronado P, Gilabert-Estelles J, Bebia V, Gil-Ibáñez B, Gil-Moreno A; SEGO Spain-GOG Group.

Ann Surg Oncol. 2020 Mar 9. doi: 10.1245/s10434-020-08329-5. [Epub ahead of print]

PMID:
32152774
2.

Fertility preservation treatment of gynecological cancer patients in Spain: a national survey (GOFER study).

Gorostidi M, Gil-Ibañez B, Alonso S, Gil-Moreno A, Hernandez A, Torné A, Zapardiel I.

Arch Gynecol Obstet. 2020 Mar;301(3):793-800. doi: 10.1007/s00404-020-05468-8. Epub 2020 Mar 2.

PMID:
32124016
3.

Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer.

Casas-Arozamena C, Díaz E, Moiola CP, Alonso-Alconada L, Ferreirós A, Abalo A, Gil CL, Oltra SS, de Santiago J, Cabrera S, Sampayo V, Bouso M, Arias E, Cueva J, Colas E, Vilar A, Gil-Moreno A, Abal M, Moreno-Bueno G, Muinelo-Romay L.

J Clin Med. 2020 Feb 21;9(2). pii: E585. doi: 10.3390/jcm9020585.

4.

Multifocal Ileal Endometriosis.

Guerrero Lojano DA, García Jiménez Á, Mañalich Barrachina L, Sánchez García JL, Gil-Moreno A, Suárez-Salvador E.

J Minim Invasive Gynecol. 2020 Feb 7. pii: S1553-4650(20)30092-3. doi: 10.1016/j.jmig.2020.02.002. [Epub ahead of print] No abstract available.

PMID:
32044427
5.

Technetium-99m-indocyanine green versus technetium-99m-methylene blue for sentinel lymph node biopsy in early-stage endometrial cancer.

Cabrera S, Bebia V, Franco-Camps S, Forcada C, Villasboas-Rosciolesi D, Navales I, Pérez-Benavente A, Gil-Moreno A.

Int J Gynecol Cancer. 2020 Mar;30(3):311-317. doi: 10.1136/ijgc-2019-000923. Epub 2020 Jan 27.

PMID:
31992599
6.

FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB Pathways.

Besso MJ, Rosso M, Lapyckyj L, Moiola CP, Matos ML, Mercogliano MF, Schillaci R, Reventos J, Colas E, Gil-Moreno A, Wernicke A, Orti R, Vazquez-Levin MH.

Front Oncol. 2019 Dec 6;9:1306. doi: 10.3389/fonc.2019.01306. eCollection 2019.

7.

Oncologic impact of micrometastases or isolated tumor cells in sentinel lymph nodes of patients with endometrial cancer: a meta-analysis.

Gómez-Hidalgo NR, Ramirez PT, Ngo B, Pérez-Hoyos S, Coreas N, Sanchez-Iglesias JL, Cabrera S, Franco S, Benavente AP, Gil-Moreno A.

Clin Transl Oncol. 2019 Dec 20. doi: 10.1007/s12094-019-02249-x. [Epub ahead of print]

PMID:
31863354
8.

Extracellular Vesicles-Based Biomarkers Represent a Promising Liquid Biopsy in Endometrial Cancer.

Herrero C, de la Fuente A, Casas-Arozamena C, Sebastian V, Prieto M, Arruebo M, Abalo A, Colás E, Moreno-Bueno G, Gil-Moreno A, Vilar A, Cueva J, Abal M, Muinelo-Romay L.

Cancers (Basel). 2019 Dec 12;11(12). pii: E2000. doi: 10.3390/cancers11122000.

9.

Long-term outcomes of retropubic tension-free vaginal tape for stress urinary incontinence after a transobturator tape failure: a retrospective study.

Sabadell J, Montero-Armengol A, Rodríguez-Mias N, Salicrú S, Gil-Moreno A, Poza JL.

Int Urogynecol J. 2019 Nov 28. doi: 10.1007/s00192-019-04169-4. [Epub ahead of print]

PMID:
31781826
10.

A Novel Saliva-Based miRNA Signature for Colorectal Cancer Diagnosis.

Rapado-González Ó, Majem B, Álvarez-Castro A, Díaz-Peña R, Abalo A, Suárez-Cabrera L, Gil-Moreno A, Santamaría A, López-López R, Muinelo-Romay L, Suarez-Cunqueiro MM.

J Clin Med. 2019 Nov 20;8(12). pii: E2029. doi: 10.3390/jcm8122029.

11.

Corrigendum to 'Chemotherapy and PARP inhibitors in heavily pretreated BRCA1/2 mutation ovarian cancer (BMOC) patients' [Gynecologic Oncology 152 (2019) 270-277].

Rodriguez-Freixinos V, Fariñas-Madrid L, Gil-Martin M, Barretina-Ginesta P, Romeo M, Villacampa G, Pardo B, Ahmed H, Recalde S, Piulats JM, Gomez-Plaza MC, Gil-Moreno A, Sala E, Martínez-Roman S, Ponce J, Melendez C, Carballas E, Dienstmann R, Oaknin A.

Gynecol Oncol. 2020 Jan;156(1):262. doi: 10.1016/j.ygyno.2019.10.020. Epub 2019 Nov 16. No abstract available.

PMID:
31744639
12.

EV-associated miRNAs from pleural lavage as potential diagnostic biomarkers in lung cancer.

Roman-Canal B, Moiola CP, Gatius S, Bonnin S, Ruiz-Miró M, González E, Ojanguren A, Recuero JL, Gil-Moreno A, Falcón-Pérez JM, Ponomarenko J, Porcel JM, Matias-Guiu X, Colas E.

Sci Rep. 2019 Oct 21;9(1):15057. doi: 10.1038/s41598-019-51578-y.

13.

The LACC Trial and Minimally Invasive Surgery in Cervical Cancer.

Vergote I, Magrina JF, Zanagnolo V, Magtibay PM, Butler K, Gil-Moreno A, Feijoo BD, Kimmig R, Canis M, Bourdel N, Ind T, Estape R, Persson J, Lim P, Coronado P, Ponce J, Lambaudie E, Van Gorp T, Maggioni A, Narducci F, Van Niewwenhuysen E, Van Trappen P.

J Minim Invasive Gynecol. 2020 Feb;27(2):462-463. doi: 10.1016/j.jmig.2019.09.767. Epub 2019 Sep 11. No abstract available.

PMID:
31520725
14.

Evaluation of the intraoperative human papillomavirus test as a marker of early cure at 12 months after electrosurgical excision procedure in women with cervical high-grade squamous intraepithelial lesion: a prospective cohort study.

Rabasa J, Bradbury M, Sanchez-Iglesias JL, Guerrero D, Forcada C, Alcalde A, Pérez-Benavente A, Cabrera S, Ramon-Cajal S, Hernandez J, Dinares C, García A, Centeno C, Gil-Moreno A.

BJOG. 2020 Jan;127(1):99-105. doi: 10.1111/1471-0528.15932. Epub 2019 Sep 25.

PMID:
31502397
15.

A giant superinfected uterine angioleiomyoma with distant septic metastases: an extremely rare presentation of a benign process and a systematic review of the literature.

Sánchez-Iglesias JL, Capote S, Cubo-Abert M, Carbonell-Socias M, Cabrera S, Illán-Hernández L, Pérez-Benavente MA, Monreal-Clua S, Gil-Moreno A.

Arch Gynecol Obstet. 2019 Oct;300(4):841-847. doi: 10.1007/s00404-019-05267-w. Epub 2019 Aug 21. Review.

PMID:
31435775
16.

Clinical management of early-stage cervical cancer: The role of sentinel lymph node biopsy in tumors ≤2 cm.

Diaz-Feijoo B, Temprana-Salvador J, Franco-Camps S, Manrique S, Colás E, Pérez-Benavente A, Gil-Moreno A.

Eur J Obstet Gynecol Reprod Biol. 2019 Oct;241:30-34. doi: 10.1016/j.ejogrb.2019.07.038. Epub 2019 Aug 7.

PMID:
31419693
17.

Nerve-sparing versus non-nerve-sparing radical hysterectomy: surgical and long-term oncological outcomes.

Gil-Moreno A, Carbonell-Socias M, Salicrú S, Bradbury M, García Á, Vergés R, Puig OP, Sánchez-Iglesias JL, Cabrera-Díaz S, de la Torre J, Gómez-Hidalgo NR, Pérez-Benavente A, Díaz-Feijoo B.

Oncotarget. 2019 Jul 16;10(44):4598-4608. doi: 10.18632/oncotarget.27078. eCollection 2019 Jul 16.

18.

MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways.

Majem B, Parrilla A, Jiménez C, Suárez-Cabrera L, Barber M, Marín A, Castellví J, Tamayo G, Moreno-Bueno G, Ponce J, Matias-Guiu X, Alameda F, Romero I, Sánchez JL, Pérez-Benavente A, Moran S, Esteller M, Reventós J, Rigau M, Gil-Moreno A, Segura MF, Santamaría A.

Oncogene. 2019 Aug;38(32):6035-6050. doi: 10.1038/s41388-019-0860-0. Epub 2019 Jul 5.

PMID:
31278368
19.

EV-associated miRNAs from peritoneal lavage as potential diagnostic biomarkers in colorectal cancer.

Roman-Canal B, Tarragona J, Moiola CP, Gatius S, Bonnin S, Ruiz-Miró M, Sierra JE, Rufas M, González E, Porcel JM, Gil-Moreno A, Falcón-Pérez JM, Ponomarenko J, Matias-Guiu X, Colas E.

J Transl Med. 2019 Jun 20;17(1):208. doi: 10.1186/s12967-019-1954-8.

20.

EV-Associated miRNAs from Peritoneal Lavage are a Source of Biomarkers in Endometrial Cancer.

Roman-Canal B, Moiola CP, Gatius S, Bonnin S, Ruiz-Miró M, González E, González-Tallada X, Llordella I, Hernández I, Porcel JM, Gil-Moreno A, Falcón-Pérez JM, Ponomarenko J, Matias-Guiu X, Colas E.

Cancers (Basel). 2019 Jun 18;11(6). pii: E839. doi: 10.3390/cancers11060839.

21.

Hysteroscopic myomectomy without anesthesia.

Rodríguez-Mias NL, Cubo-Abert M, Gomila-Villalonga L, Gómez-Cabeza J, Poza-Barrasús JL, Gil-Moreno A.

Obstet Gynecol Sci. 2019 May;62(3):183-185. doi: 10.5468/ogs.2019.62.3.183. Epub 2019 Apr 4.

22.

Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration study.

Visser NCM, van der Putten LJM, van Egerschot A, Van de Vijver KK, Santacana M, Bronsert P, Hirschfeld M, Colas E, Gil-Moreno A, Garcia A, Mancebo G, Alameda F, Krakstad C, Tangen IL, Huvila J, Schrauwen S, Koskas M, Walker F, Weinberger V, Minar L, Hausnerova J, Snijders MPLM, van den Berg-van Erp S, Matias-Guiu X, Trovik J, Amant F, Massuger LFAG, Bulten J, Pijnenborg JMA.

Hum Pathol. 2019 Jul;89:90-98. doi: 10.1016/j.humpath.2019.04.014. Epub 2019 May 3.

PMID:
31054899
23.

Poor outcome in hypoxic endometrial carcinoma is related to vascular density.

Reijnen C, van Weelden WJ, Arts MSJP, Peters JP, Rijken PF, van de Vijver K, Santacana M, Bronsert P, Bulten J, Hirschfeld M, Colas E, Gil-Moreno A, Reques A, Mancebo G, Krakstad C, Trovik J, Haldorsen IS, Huvila J, Koskas M, Weinberger V, Minar L, Jandakova E, Snijders MPLM, van den Berg-van Erp S, Küsters-Vandevelde HVN, Matias-Guiu X, Amant F; ENITEC-consortium, Massuger LFAG, Bussink J, Pijnenborg JMA.

Br J Cancer. 2019 May;120(11):1037-1044. doi: 10.1038/s41416-019-0461-2. Epub 2019 Apr 23.

PMID:
31011231
24.

Risk factors for anastomotic leakage after colorectal resection in ovarian cancer surgery: A multi-centre study.

Lago V, Fotopoulou C, Chiantera V, Minig L, Gil-Moreno A, Cascales-Campos PA, Jurado M, Tejerizo A, Padilla-Iserte P, Malune ME, Di Donna MC, Marina T, Sánchez-Iglesias JL, Olloqui A, García-Granero Á, Matute L, Fornes V, Domingo S.

Gynecol Oncol. 2019 Jun;153(3):549-554. doi: 10.1016/j.ygyno.2019.03.241. Epub 2019 Apr 3.

PMID:
30952369
25.

Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer.

Felip I, Moiola CP, Megino-Luque C, Lopez-Gil C, Cabrera S, Solé-Sánchez S, Muñoz-Guardiola P, Megias-Roda E, Pérez-Montoyo H, Alfon J, Yeste-Velasco M, Santacana M, Dolcet X, Reques A, Oaknin A, Rodríguez-Freixinos V, Lizcano JM, Domènech C, Gil-Moreno A, Matias-Guiu X, Colas E, Eritja N.

Gynecol Oncol. 2019 May;153(2):425-435. doi: 10.1016/j.ygyno.2019.03.002. Epub 2019 Mar 7.

PMID:
30853360
26.

Minimally Invasive or Abdominal Radical Hysterectomy for Cervical Cancer.

Gil-Moreno A, Magrina JF.

N Engl J Med. 2019 Feb 21;380(8):794. doi: 10.1056/NEJMc1816590. No abstract available.

PMID:
30789680
27.

Proteomic Characterization of Epithelial-Like Extracellular Vesicles in Advanced Endometrial Cancer.

Mariscal J, Fernandez-Puente P, Calamia V, Abalo A, Santacana M, Matias-Guiu X, Lopez-Lopez R, Gil-Moreno A, Alonso-Alconada L, Abal M.

J Proteome Res. 2019 Mar 1;18(3):1043-1053. doi: 10.1021/acs.jproteome.8b00750. Epub 2019 Jan 11.

PMID:
30585730
28.

Lgr5 Does Not Vary Throughout the Menstrual Cycle in Endometriotic Human Eutopic Endometrium.

Vallvé-Juanico J, Barón C, Suárez-Salvador E, Castellví J, Ballesteros A, Gil-Moreno A, Santamaria X.

Int J Mol Sci. 2018 Dec 21;20(1). pii: E22. doi: 10.3390/ijms20010022.

29.

Chemotherapy and PARP inhibitors in heavily pretreated BRCA1/2 mutation ovarian cancer (BMOC) patients.

Rodriguez-Freixinos V, Fariñas-Madrid L, Gil-Martin M, Barretina-Ginesta P, Romeo M, Villacampa G, Pardo B, Ahmed H, Recalde S, Piulats JM, Gómez-Plaza MC, Gil-Moreno A, Sala E, Martínez-Román S, Ponce J, Meléndez C, Carballas E, Dienstmann R, Oaknin A.

Gynecol Oncol. 2019 Feb;152(2):270-277. doi: 10.1016/j.ygyno.2018.11.036. Epub 2018 Dec 12. Erratum in: Gynecol Oncol. 2020 Jan;156(1):262.

PMID:
30551885
30.

External validation of de novo stress urinary incontinence prediction model after vaginal prolapse surgery.

Sabadell J, Salicrú S, Montero-Armengol A, Rodriguez-Mias N, Gil-Moreno A, Poza JL.

Int Urogynecol J. 2019 Oct;30(10):1719-1723. doi: 10.1007/s00192-018-3805-1. Epub 2018 Nov 15.

PMID:
30443760
31.

Impact of Laparoscopy to Assess Resectability in Stage IIIC Epithelial Ovarian, Tubal and Peritoneal Cancer Patients.

Sánchez-Iglesias JL, Perez-Benavente A, Correa-Paris A, De la Torre Fernandez de Vega J, Carbonell Socias M, Gil-Moreno A.

Gynecol Obstet Invest. 2019;84(3):259-267. doi: 10.1159/000493794. Epub 2018 Nov 14.

PMID:
30428466
32.

Optimization of surgical treatment of advanced ovarian cancer: a Spanish expert perspective.

Minig L, de Santiago J, Domingo S, Gil-Moreno A, Martínez S, Rodríguez-Garzotto A, Chiva L.

Clin Transl Oncol. 2019 May;21(5):656-664. doi: 10.1007/s12094-018-1967-4. Epub 2018 Oct 30.

PMID:
30377941
33.

Role of office hysteroscopic morcellation and 3-dimensional transvaginal ultrasound in conservative management of retained placenta accreta.

Capote S, Cubo-Abert M, Casellas-Caro M, Sánchez-Iglesias JL, Gomez-Cabeza JJ, Gil-Moreno A.

Eur J Obstet Gynecol Reprod Biol. 2018 Nov;230:199-200. doi: 10.1016/j.ejogrb.2018.09.024. Epub 2018 Sep 14. No abstract available.

PMID:
30249453
34.

Surgical approaches in women with endometrial cancer with a body mass index greater than 35 kg/m2.

Raventós-Tato RM, de la Torre-Fernández de Vega J, Sánchez-Iglesias JL, Díaz-Feijoó B, Sabadell J, Pérez-Benavente MA, Gil-Moreno A.

J Obstet Gynaecol Res. 2019 Jan;45(1):195-202. doi: 10.1111/jog.13789. Epub 2018 Sep 6.

PMID:
30191628
35.

Vaginal Intraepithelial Neoplasia: Clinical Presentation, Management, and Outcomes in Relation to HIV Infection Status.

Bradbury M, Xercavins N, García-Jiménez Á, Pérez-Benavente A, Franco-Camps S, Cabrera S, Sánchez-Iglesias JL, De La Torre J, Díaz-Feijoo B, Gil-Moreno A, Centeno-Mediavilla C.

J Low Genit Tract Dis. 2019 Jan;23(1):7-12. doi: 10.1097/LGT.0000000000000431.

PMID:
30161052
36.

Patient-Derived Xenograft Models for Endometrial Cancer Research.

Moiola CP, Lopez-Gil C, Cabrera S, Garcia A, Van Nyen T, Annibali D, Fonnes T, Vidal A, Villanueva A, Matias-Guiu X, Krakstad C, Amant F, Gil-Moreno A, Colas E.

Int J Mol Sci. 2018 Aug 17;19(8). pii: E2431. doi: 10.3390/ijms19082431. Review.

37.

Radical Hysterectomy: Efficacy and Safety in the Dawn of Minimally Invasive Techniques.

Gil-Moreno A, Carbonell-Socias M, Salicrú S, Centeno-Mediavilla C, Franco-Camps S, Colas E, Oaknin A, Pérez-Benavente A, Díaz-Feijoo B.

J Minim Invasive Gynecol. 2019 Mar - Apr;26(3):492-500. doi: 10.1016/j.jmig.2018.06.007. Epub 2018 Jun 13.

PMID:
29908339
38.

Laparoscopic Extraperitoneal Pelvic Lymph Node Debulking in Locally Advanced Cervical Cancer.

Diaz-Feijoo B, Luna-Guibourg R, Cabrera S, Manrique S, Gil-Moreno A.

J Minim Invasive Gynecol. 2019 Feb;26(2):366. doi: 10.1016/j.jmig.2018.05.008. Epub 2018 May 18.

PMID:
29783001
39.

ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer.

Devis L, Martinez-Garcia E, Moiola CP, Quiles MT, Arbos MA, Stirbat TV, Brochard-Wyart F, García Á, Alonso-Alconada L, Abal M, Diaz-Feijoo B, Thomas W, Dufour S, Mancebo G, Alameda F, Reventos J, Gil-Moreno A, Colas E.

Oncotarget. 2018 Mar 30;9(24):16648-16664. doi: 10.18632/oncotarget.24625. eCollection 2018 Mar 30.

40.

Myeloid sarcoma as a simulator of advanced ovarian cancer: A case report.

Capote S, Sánchez-Iglesias JL, Cubo-Abert M, De la Torre J, Centeno-Mediavilla C, Pérez-Benavente A, Gil-Moreno A.

Eur J Obstet Gynecol Reprod Biol. 2018 Jun;225:259-260. doi: 10.1016/j.ejogrb.2018.03.056. Epub 2018 Mar 28. No abstract available.

PMID:
29666016
41.

Human salivary microRNAs in Cancer.

Rapado-González Ó, Majem B, Muinelo-Romay L, Álvarez-Castro A, Santamaría A, Gil-Moreno A, López-López R, Suárez-Cunqueiro MM.

J Cancer. 2018 Jan 6;9(4):638-649. doi: 10.7150/jca.21180. eCollection 2018. Review.

42.

Nerve-Sparing Technique during Laparoscopic Radical Hysterectomy: Critical Steps.

Díaz-Feijoo B, Bradbury M, Pérez-Benavente A, Franco-Camps S, Gil-Moreno A.

J Minim Invasive Gynecol. 2018 Nov - Dec;25(7):1144-1145. doi: 10.1016/j.jmig.2018.01.034. Epub 2018 Feb 9.

PMID:
29432901
43.

Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study.

van der Putten LJM, Visser NCM, van de Vijver K, Santacana M, Bronsert P, Bulten J, Hirschfeld M, Colas E, Gil-Moreno A, Garcia A, Mancebo G, Alameda F, Trovik J, Kopperud RK, Huvila J, Schrauwen S, Koskas M, Walker F, Weinberger V, Minar L, Jandakova E, Snijders MPLM, van den Berg-van Erp S, Matias-Guiu X, Salvesen HB, Werner HMJ, Amant F, Massuger LFAG, Pijnenborg JMA.

Int J Gynecol Cancer. 2018 Mar;28(3):514-523. doi: 10.1097/IGC.0000000000001187.

PMID:
29324536
44.

Pelvic exenteration with rectal resection for different types of malignancies at two tertiary referral centres.

Garcia-Granero A, Biondo S, Espin-Basany E, González-Castillo A, Valverde S, Trenti L, Gil-Moreno A, Kreisler E.

Cir Esp. 2018 Mar;96(3):138-148. doi: 10.1016/j.ciresp.2017.11.001. Epub 2017 Dec 8. English, Spanish.

PMID:
29229359
45.

Advances in endometrial cancer protein biomarkers for use in the clinic.

Martinez-Garcia E, Lopez-Gil C, Campoy I, Vallve J, Coll E, Cabrera S, Ramon Y Cajal S, Matias-Guiu X, Van Oostrum J, Reventos J, Gil-Moreno A, Colas E.

Expert Rev Proteomics. 2018 Jan;15(1):81-99. doi: 10.1080/14789450.2018.1410061. Epub 2017 Nov 30. Review.

PMID:
29183259
46.

Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways.

Cuppens T, Moisse M, Depreeuw J, Annibali D, Colas E, Gil-Moreno A, Huvila J, Carpén O, Zikán M, Matias-Guiu X, Moerman P, Croce S, Lambrechts D, Amant F.

Int J Cancer. 2018 Mar 15;142(6):1230-1243. doi: 10.1002/ijc.31129. Epub 2017 Nov 7.

47.

Laparoscopic Isthmocele Repair with Hysteroscopic Assistance.

Suarez Salvador E, Haladjian MC, Bradbury M, Cubo-Abert M, Manalich Barrachina L, Vila Escude E, Puig OP, Gil-Moreno A.

J Minim Invasive Gynecol. 2018 May - Jun;25(4):576-577. doi: 10.1016/j.jmig.2017.10.005. Epub 2017 Oct 12.

PMID:
29032251
48.

E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness.

Rosso M, Majem B, Devis L, Lapyckyj L, Besso MJ, Llauradó M, Abascal MF, Matos ML, Lanau L, Castellví J, Sánchez JL, Pérez Benavente A, Gil-Moreno A, Reventós J, Santamaria Margalef A, Rigau M, Vazquez-Levin MH.

PLoS One. 2017 Sep 21;12(9):e0184439. doi: 10.1371/journal.pone.0184439. eCollection 2017.

49.

Aberrant expression of epithelial leucine-rich repeat containing G protein-coupled receptor 5-positive cells in the eutopic endometrium in endometriosis and implications in deep-infiltrating endometriosis.

Vallvé-Juanico J, Suárez-Salvador E, Castellví J, Ballesteros A, Taylor HS, Gil-Moreno A, Santamaria X.

Fertil Steril. 2017 Nov;108(5):858-867.e2. doi: 10.1016/j.fertnstert.2017.08.018. Epub 2017 Sep 15.

PMID:
28923287
50.

Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis.

Altadill T, Dowdy TM, Gill K, Reques A, Menon SS, Moiola CP, Lopez-Gil C, Coll E, Matias-Guiu X, Cabrera S, Garcia A, Reventos J, Byers SW, Gil-Moreno A, Cheema AK, Colas E.

Sci Rep. 2017 Aug 18;7(1):8803. doi: 10.1038/s41598-017-09169-2.

Supplemental Content

Loading ...
Support Center